Analysis of HPV-16-L1-specific antibodies and correlation with risk for oropharyngeal cancer (OPSCC) in a prospective cohort of 45.000 individuals. Oral presentation, International symposium of HPV infection in Head and Neck cancer - Loewenthal, M; Busch, C-J; Rieckmann, T
Nov. 3rd – 4th, 2017